Novel pharmacologic treatment in acute binge eating disorder - role of lisdexamfetamine.

Guerdjikova, Anna I; Mori, Nicole; Casuto, Leah S; McElroy, Susan L

Guerdjikova, Anna I; Mori, Nicole; Casuto, Leah S; McElroy, Susan L.

Afiliação

Guerdjikova AI; Lindner Center of HOPE, Mason, OH, USA; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Mori N; Lindner Center of HOPE, Mason, OH, USA; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Casuto LS; Lindner Center of HOPE, Mason, OH, USA; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
McElroy SL; Lindner Center of HOPE, Mason, OH, USA; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Neuropsychiatr Dis Treat ; 12: 833-41, 2016.

Article em En | MEDLINE | ID: mdl-27143885

Palavras-chave

Vyvanse; approved medication; binging; overeating; stimulant

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Neuropsychiatr Dis Treat Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Nova Zelândia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google